Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents
Open accessAbstract
OBJECTIVE: To examine the effects of early stimulant treatment on subsequent risk for cigarette smoking and substance use disorders (SUDs) in adolescents with attention-deficit/hyperactivity disorder (ADHD). DESIGN: Case-controlled, prospective, 5-year follow-up study. SETTING: Massachusetts General Hospital, Boston. PARTICIPANTS: Adolescents with and without ADHD from psychiatric and pediatric sources. Blinded interviewers determined all diagnoses using structured interviews. Intervention Naturalistic treatment exposure with psychostimulants for ADHD. MAIN OUTCOME MEASURES: We modeled time to onset of SUDs and smoking as a function of stimulant treatment. RESULTS: We ascertained 114 subjects with ADHD (mean age at follow-up, 16.2 years) having complete medication and SUD data; 94 of the subjects were treated with stimulants. There were no differences in SUD risk factors between naturalistically treated and untreated groups other than family history of ADHD. We found no increased risks for cigarette smoking or SUDs associated with stimulant therapy. We found significant protective effects of stimulant treatment on the development of any SUD (hazard ratio [HR], 0.27; 95% confidence interval [CI], 0.13-0.60; chi(2)(113) = 10.57, P = .001) and cigarette smoking (HR, 0.28; 95% CI, 0.14-0.60; chi(2)(111) = 10.05, P = .001) that were maintained when controlling for conduct disorder. We found no effects of time to onset or duration of stimulant therapy on subsequent SUDs or cigarette smoking in subjects with ADHD. CONCLUSION: Stimulant therapy does not increase but rather reduces the risk for cigarette smoking and SUDs in adolescents with ADHD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The finding that earlier initiation of treatment was associated with lower SUD odds was replicated in four other studies.
“This finding was replicated in four other studies, suggesting that earlier initiation of treatment may lead to better outcomes for SUD (Wilens et al. 2008; Dalsgaard et al. 2014; Levy et al. 2014; McCabe et al. 2016).”
From The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders (2022) · cites this paper as Wilens et al. 2008
The Results (Onset and Duration; page unavailable) report no effect of the age at which stimulant treatment began on subsequent SUD. Although the paper found lower SUD risk among stimulant-treated girls overall, it does not replicate the claimed finding that earlier initiation was associated with lower SUD odds. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredEarlier initiation of treatment may lead to better outcomes for SUD.
“This finding was replicated in four other studies, suggesting that earlier initiation of treatment may lead to better outcomes for SUD (Wilens et al. 2008; Dalsgaard et al. 2014; Levy et al. 2014; McCabe et al. 2016).”
From The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders (2022) · cites this paper as Wilens et al. 2008
The Results (Onset and Duration; page unavailable) report no effect of age at initiation of stimulant therapy on subsequent SUD in adolescent girls with ADHD. The study found a protective association for stimulant treatment overall, but not better SUD outcomes with earlier initiation. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredTreatment with stimulants can help lessen the likelihood of other psychiatric comorbidities during adolescence, including cigarette use and substance abuse.
“some studies suggest that treatment with stimulants can help to lessen the likelihood of other psychiatric comorbidities during adolescence [49], including cigarette use and substance abuse [50].”
From Advances in understanding and treating ADHD (2011) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · see citing works
Self-citationKessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · see citing works
Self-citationBiederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · see citing works
Self-citationMannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368 · see citing works
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,277 · see citing works
Self-citationFreeman, H. E., & Robins, L. N. (1967) · American Sociological Review · doi:10.2307/2091752 · Cited by 1,221 · see citing works
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927 · see citing works
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872 · see citing works
Self-citationBIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850 · see citing works
Self-citationChildhood predictors of adolescent substance use in a longitudinal study of children with ADHD
Molina, B. S. G., & Pelham, W. E. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.497 · Cited by 706 · see citing works
Attention-Deficit, S. O., & Disorder, H. (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 636 · see citing works
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528 · see citing works
Self-citationADHD is associated with early initiation of cigarette smoking in children and adolescents.
Milberger, S., Biederman, J., Faraone, S., Chen, L., & Jones, J. (1997) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/00004583-199701000-00015 · Cited by 513 · see citing works
Self-citationPharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493 · see citing works
Self-citationLambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465 · see citing works
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442 · see citing works
Effects of ADHD, Conduct Disorder, and Gender on Substance Use and Abuse in Adolescence
Disney, E. R., Elkins, I. J., McGue, M. K., & Iacono, W. G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1515 · Cited by 409 · see citing works
Wolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404 · see citing works
Self-citationMcGough, J. J., Smalley, S. L., McCracken, J. T., YANG, M. H., Del’Homme, M., Lynn, D. E., & Loo, S. K. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1621 · Cited by 398 · see citing works
Hinshaw, S. P. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.5.1086 · Cited by 379 · see citing works
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review
Kollins, S. H., MacDonald, E. K., & Rush, C. R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00464-6 · Cited by 365 · see citing works
BIEDERMAN, J., FARAONE, S. V., MICK, E., WILLIAMSON, S., WILENS, T. E., SPENCER, T. J., WEBER, W., JETTON, J., KRAUS, I., PERT, J., et al. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199908000-00012 · Cited by 364 · see citing works
Self-citationWilens, T., Biederman, J., Mick, E., Faraone, S., & Spencer, T. (1997) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-199708000-00001 · Cited by 320 · see citing works
Self-citationBarkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003) · Pediatrics · doi:10.1542/peds.111.1.97 · Cited by 274 · see citing works
Wilens, T. E. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00113-8 · Cited by 264 · see citing works
Self-citationMOLINA, B. S. G., FLORY, K., HINSHAW, S. P., GREINER, A. R., ARNOLD, L. E., SWANSON, J. M., HECHTMAN, L., JENSEN, P. S., VITIELLO, B., HOZA, B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d96 · Cited by 255 · see citing works
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248 · see citing works
Katusic, S. K., Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Leibson, C. L., & Jacobsen, S. J. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.764 · Cited by 175 · see citing works
Biederman, J., Monuteaux, M. C., Mick, E. O., Wilens, T. E., Fontanella, J. A., Poetzl, K. M., Kirk, T., Masse, J. J., & Faraone, S. V. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.009 · Cited by 172 · see citing works
Self-citationBiederman, J., Monuteaux, M. C., Mick, E. O., Spencer, T. J., Wilens, T. E., Klein, K. L., Price, J., & Faraone, S. V. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.031 · Cited by 168 · see citing works
Self-citationMilberger, S., Biederman, J., Faraone, S. V., Wilens, T., & Chu, M. P. (1997) · American Journal on Addictions · doi:10.3109/10550499709005063 · Cited by 113 · see citing works
Self-citationVitiello, B. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143384 · Cited by 76 · see citing works
Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies
Huss, M., & Lehmkuhl, U. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s09 · Cited by 64 · see citing works
Monuteaux, M. C., Spencer, T. J., Faraone, S. V., Wilson, A., & Biederman, J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0718 · Cited by 48 · see citing works
Self-citationAugustyniak, P. N., Kourrich, S., Rezazadeh, S. M., Stewart, J., & Arvanitogiannis, A. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.09.014 · Cited by 37 · see citing works
Gignac, M., Wilens, T. E., Biederman, J., Kwon, A., Mick, E., & Swezey, A. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.742 · Cited by 33 · see citing works
Self-citationMilberger, S., Faraone, S., Biederman, J., Chu, M. P., & Wilens, T. (1998) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.152.10.945 · Cited by 32 · see citing works
Self-citationKemp, C. (1999) · AAP News · Cited by 12 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [2]Faraone SV The Worldwide Prevalence of ADHD: Is it an American Condition? World Psychiatry 2003 2 2 104 113 16946911 PMC1525089
- [6]Weiss G Attention-Deficit Disorder Child and Adolescent Psychiatric Clinics of North America 1992 W.B. Saunders Company Philadelphia
Cited by
Sorted by citations
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · see citing works
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535 · see citing works
Attention-deficit/hyperactivity disorder and adverse health outcomes
Nigg, J. T. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.11.005 · Cited by 436 · see citing works
Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD
Wilens, T. E., Martelon, M., Joshi, G., Bateman, C., Fried, R., Petty, C., & Biederman, J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.01.021 · Cited by 339 · see citing works
Self-citationUnderstanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood
Wilens, T. E., & Spencer, T. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2206 · Cited by 324 · see citing works
Self-citationMolina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246 · see citing works
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., & Barratt, A. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.5335 · Cited by 224 · see citing works
Smoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works
Stimulant Medication and Substance Use Outcomes
Humphreys, K. L., Eng, T., & Lee, S. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1273 · Cited by 211 · see citing works
“05) after the removal of one study.(36) When the model was reanalyzed with the study by Wilens et al(36) removed, no significant heterogeneity was found, and the estimated effect was 1.”
MethodAdult ADHD and its comorbidities, with a focus on bipolar disorder
Klassen, L. J., Katzman, M. A., & Chokka, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.036 · Cited by 205 · see citing works
Turgay, A., Goodman, D. W., Asherson, P. J., Lasser, R. A., Babcock, T. F., Pucci, M. L., Barkley, R. A., & ADHD Transition Phase Model Working Group (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06628 · Cited by 205 · see citing works
The Potential for Misuse and Abuse of Medications in ADHD: A Review
Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2801 · Cited by 198 · see citing works
Enhancing ADHD Medication Adherence: Challenges and Opportunities
Charach, A., & Fernandez, R. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0371-6 · Cited by 158 · see citing works
Dalsgaard, S., Mortensen, P. B., Frydenberg, M., & Thomsen, P. H. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.09.002 · Cited by 144 · see citing works
“28), but not alcohol abuse at age 16 (Wilens et al., 2008).”
BackgroundResultInfluentialAdvances in understanding and treating ADHD
Antshel, K. M., Hargrave, T. M., Simonescu, M., Kaul, P., Hendricks, K., & Faraone, S. V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-72 · Cited by 140 · see citing works
Self-citationPollak, Y., Dekkers, T. J., Shoham, R., & Huizenga, H. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1019-y · Cited by 138 · see citing works
Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Harstad, E., Levy, S., COMMITTEE ON SUBSTANCE ABUSE, Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., Siqueira, L. M., & Smith, V. C. (2014) · Pediatrics · doi:10.1542/peds.2014-0992 · Cited by 131 · see citing works
Torrens, M., Rossi, P. C., Martinez-Riera, R., Martinez-Sanvisens, D., & Bulbena, A. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.663296 · Cited by 122 · see citing works
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
Wilens, T. E., Morrison, N. R., & Prince, J. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.137 · Cited by 113 · see citing works
Self-citationMechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse
Cross, S. J., Lotfipour, S., & Leslie, F. M. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1209512 · Cited by 101 · see citing works
The intersection of attention-deficit/hyperactivity disorder and substance abuse
Wilens, T. E., & Morrison, N. R. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328345c956 · Cited by 99 · see citing works
Self-citationMcRae‐Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., White, K., & Brady, K. T. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00076.x · Cited by 90 · see citing works
Groenman, A. P., Oosterlaan, J., Rommelse, N. N. J., Franke, B., Greven, C. U., Hoekstra, P. J., Hartman, C. A., Luman, M., Roeyers, H., Oades, R. D., et al. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.124784 · Cited by 85 · see citing works
Self-citationMcCabe, S. E., Dickinson, K., West, B. T., & Wilens, T. E. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.03.011 · Cited by 82 · see citing works
Self-citationGonon, F., Konsman, J. P., Cohen, D., & Boraud, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044275 · Cited by 77 · see citing works
Causal Factors of Increased Smoking in ADHD: A Systematic Review
van Amsterdam, J., van der Velde, B., Schulte, M., & van den Brink, W. (2018) · Substance Use & Misuse · doi:10.1080/10826084.2017.1334066 · Cited by 63 · see citing works
Reducing substance use during adolescence: a translational framework for prevention
Stanis, J. J., & Andersen, S. L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3393-1 · Cited by 69 · see citing works
Shier, A. C., Reichenbacher, T., Ghuman, H. S., & GHUMAN, J. K. (2012) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6691 · Cited by 69 · see citing works
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis
Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H. (2014) · Pediatrics · doi:10.1542/peds.2014-0179 · Cited by 55 · see citing works
Self-citationLong-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder
Huang, Y., & Tsai, M.-H. (2011) · CNS Drugs · doi:10.2165/11589380-000000000-00000 · Cited by 54 · see citing works
Buitelaar, J. K. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000154 · Cited by 53 · see citing works
Clemow, D. B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_426 · Cited by 50 · see citing works
Gehricke, J., Hong, N., Whalen, C. K., Steinhoff, K. W., & Wigal, T. L. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0017441 · Cited by 46 · see citing works
Sleep and Substance Use and Abuse in Adolescents
Gromov, I., & Gromov, D. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.04.004 · Cited by 43 · see citing works
Patientsʼ Attitudes towards Generic Substitution of Oral Atypical Antipsychotics
Roman, B. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00006 · Cited by 42 · see citing works
Chelaru, M. I., Yang, P. B., & Dafny, N. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.027 · Cited by 42 · see citing works
Mattingly, G. W., Wilson, J. A., Ugarte, L., & Glaser, P. E. A. (2020) · CNS Spectrums · doi:10.1017/s1092852919001822 · Cited by 40 · see citing works
Perugi, G., Pallucchini, A., Rizzato, S., de Rossi, P., Sani, G., Maremmani, A. G. I., Pinzone, V., & Maremmani, I. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1551878 · Cited by 34 · see citing works
Groenman, A. P., Schweren, L. J. S., Weeda, W., Luman, M., Noordermeer, S. D. S., Heslenfeld, D. J., Franke, B., Faraone, S. V., Rommelse, N., Hartman, C. A., et al. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01283-y · Cited by 36 · see citing works
Self-citationADHD Symptoms and Financial Distress
Liao, C. (2020) · European Finance Review · doi:10.1093/rof/rfaa013 · Cited by 35 · see citing works
Methylphenidate effects in the young brain: friend or foe?
Loureiro-Vieira, S., Costa, V. M., Bastos, M. L., Carvalho, F., & Capela, J. P. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.04.002 · Cited by 27 · see citing works
Sihvola, E., Rose, R. J., Dick, D. M., Korhonen, T., Pulkkinen, L., Raevuori, A., MARTTUNEN, M. J., & Kaprio, J. A. (2011) · Psychological Medicine · doi:10.1017/s0033291711000791 · Cited by 34 · see citing works
Parents’ Perspectives About Factors Influencing Adherence to Pharmacotherapy for ADHD
Ahmed, R. A., Borst, J., Wei, Y. C., & Aslani, P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713499231 · Cited by 33 · see citing works
Cunha, P. J., Gonçalves, P. D., Ometto, M., dos Santos, B., Nicastri, S., Busatto, G. F., & de Andrade, A. G. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00126 · Cited by 33 · see citing works
A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program
Hendricks, E. J., & Greenway, F. L. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181d070d7 · Cited by 32 · see citing works
Khan, M. U., & Aslani, P. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0153 · Cited by 32 · see citing works
Lile, J. A., Babalonis, S. L., Emurian, C. S., Martin, C. A., Wermeling, D. P., & Kelly, T. H. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010375956 · Cited by 31 · see citing works
Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism in mice
Reynolds, L. M., Hernandez, G., MacGowan, D., Popescu, C., Nouel, D., Cuesta, S., Burke, S., Savell, K. E., Zhao, J., Restrepo-Lozano, J. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39665-1 · Cited by 30 · see citing works
Gray, W. N., Kavookjian, J., Shapiro, S. K., Wagoner, S. T., Schaefer, M. R., Rawlinson, A. R., & Hinnant, J. B. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000511 · Cited by 30 · see citing works
Bhang, S., Kwack, Y. S., Joung, Y., Lee, S. I., Kim, B., Sohn, S. H., Chung, U., Yang, J.-W., Hong, M., Bahn, G. H., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.2.158 · Cited by 29 · see citing works
Patientsʼ Attitudes towards Generic Substitution of Oral Atypical Antipsychotics
Roman, B. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00003 · Cited by 28 · see citing works
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Szobot, C. M., & Bukstein, O. G. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.003 · Cited by 26 · see citing works
Ivanov, I., Bjork, J. M., Blair, J., & Newcorn, J. H. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104575 · Cited by 25 · see citing works
Wilens, T. E., Woodward, D. W., Ko, J. D., Berger, A. F., Burke, C., & Yule, A. M. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0016 · Cited by 26 · see citing works
Self-citationTaubin, D., Wilson, J. C., & Wilens, T. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.01.005 · Cited by 15 · see citing works
Self-citationYoung, S., & Sedgwick, O. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1059756 · Cited by 24 · see citing works
Schellekens, A., van den Brink, W., Kiefer, F., & Goudriaan, A. E. (2020) · European Addiction Research · doi:10.1159/000509267 · Cited by 25 · see citing works
Young, S., Abbasian, C., Al‐Attar, Z., Branney, P., Colley, B., Cortese, S., Cubbin, S., Deeley, Q., Gudjonsson, G. H., Hill, P., et al. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i3.84 · Cited by 25 · see citing works
Leach, P. T., Cordero, K. A., & Gould, T. J. (2013) · Behavioral Neuroscience · doi:10.1037/a0031913 · Cited by 23 · see citing works
Nunes, E. V., Covey, L. S., Brigham, G., Hu, M.-C., Levin, F. R., Somoza, E. C., & Winhusen, T. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08155 · Cited by 22 · see citing works
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Bukstein, O. G. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_148 · Cited by 19 · see citing works
Cost effectiveness of optimal treatment of ADHD in Israel: a suggestion for national policy
Ornoy, A., & Spivak, A. (2019) · Health Economics Review · doi:10.1186/s13561-019-0240-z · Cited by 19 · see citing works
Approach to diagnosis and management of childhood attention deficit hyperactivity disorder.
Jerome, D., & Jerome, L. (2020) · Europe PMC (PubMed Central) · Cited by 19 · see citing works
Riegler, A., Völkl-Kernstock, S., Lesch, O., Walter, H., & Skala, K. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.072 · Cited by 20 · see citing works
Torgersen, T., Gjervan, B., Rasmussen, K. B., Vaaler, A., & Nordahl, H. M. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0094-2 · Cited by 18 · see citing works
Madsen, A. G., & Dalsgaard, S. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2013.768293 · Cited by 17 · see citing works
Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder
Riglin, L., Todd, A., Blakey, R., Shakeshaft, A., Stergiakouli, E., Smith, G. D., Tilling, K. M., & Thapar, A. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14379 · Cited by 17 · see citing works
Prevalence of ADHD among students of zahedan university of medical science in iran.
Mosalanejad, M., Mosalanejad, L., & Lashkarpour, K. (2013) · Europe PMC (PubMed Central) · Cited by 17 · see citing works
Evren, C., Dalbudak, E., Evren, B., Can, Y., & Umut, G. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.06.002 · Cited by 17 · see citing works
McBurnett, K., & Pfiffner, L. J. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.11.2084 · Cited by 18 · see citing works
The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
Bieś, R., Fojcik, J., Warchala, A., Trędzbor, B., Krysta, K., Piekarska-Bugiel, K., & Krzystanek, M. (2023) · Pharmaceuticals · doi:10.3390/ph16091292 · Cited by 16 · see citing works
Exploring the Relationship Among ADHD, Stimulants, and Substance Abuse
Nelson, A., & Galon, P. (2012) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/j.1744-6171.2012.00322.x · Cited by 12 · see citing works
Jain, R., & Stark, J. G. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1218259 · Cited by 12 · see citing works
Dual Disorders: Addiction and Other Mental Disorders. Integrating Mental Health
Szerman, N., Parro-Torres, C., Didia-Attas, J., & el‐Guebaly, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_7 · Cited by 12 · see citing works
Martínez-Raga, J., Knecht, C., de Alvaro, R., Szerman, N., & Ruíz, P. (2013) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318277060c · Cited by 14 · see citing works
Adolescent Substance Involvement Use and Abuse
Monasterio, E. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.05.009 · Cited by 11 · see citing works
Weiss, F., Tidona, S., Carli, M., Perugi, G., & Scarselli, M. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830154002 · Cited by 11 · see citing works
Daigre, C., Terán, A., García-Vicent, V., & Roncero, C. (2013) · Adicciones · doi:10.20882/adicciones.65 · Cited by 10 · see citing works
Brancati, G. E., Rosa, U. D., Dominicis, F. D., Petrucci, A., Nannini, A., Medda, P., Schiavi, E., & Perugi, G. (2023) · Brain Sciences · doi:10.3390/brainsci13091251 · Cited by 9 · see citing works
Neuroscience: Rethinking rehab
Schnabel, J. (2009) · Nature · doi:10.1038/458025a · Cited by 9 · see citing works
OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder
McBurnett, K., & Starr, H. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.546058 · Cited by 8 · see citing works
Bhang, S., Hwang, J., Kwak, Y.-S., Joung, Y., Lee, S. I., Kim, B., Sohn, S. H., Chung, U., Yang, J.-W., Hong, M., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.8.1284 · Cited by 8 · see citing works
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7 · see citing works
Obioha, O. A., & ADESMAN, A. R. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000053 · Cited by 7 · see citing works
Methylphenidate Transdermal System in Adults With Past Stimulant Misuse
McRae‐Clark, A. L., Brady, K. T., Hartwell, K. J., White, K., & Carter, R. E. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710371171 · Cited by 7 · see citing works
Coetzee, C., Schellekens, A., Truter, I., & Meyer, A. (2022) · European Addiction Research · doi:10.1159/000526386 · Cited by 6 · see citing works
Mitchell, R. H. B., & Goldstein, B. I. (2014) · Psychiatric Annals · doi:10.3928/00485713-20141003-04 · Cited by 6 · see citing works
Bateman, J., Gilvarry, E. A., Tziggili, M., CROME, I. B., Mirza, K., & McArdle, P. (2013) · Child and Adolescent Mental Health · doi:10.1111/camh.12013 · Cited by 6 · see citing works
Attention‐Deficit Hyperactivity Disorder
Rube, D. M., & Kaur, T. (2012) · Wiley eBooks · doi:10.1002/9781119962229.ch10 · Cited by 6 · see citing works
Irish adolescents with ADHD and comorbid substance use disorder
Edokpolo, O., Nkire, N., & Smyth, B. P. (2010) · Irish Journal of Psychological Medicine · doi:10.1017/s079096670000135x · Cited by 5 · see citing works
La prescription actuelle du méthylphénidate (Ritaline®)
Heuzey, M.-F. L. (2009) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2009.07.006 · Cited by 5 · see citing works
Treatment of Comorbid Substance Use Disorders and ADHD in Youth
Carrellas, N. W., Wilens, T., & Anselmo, R. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0072-y · Cited by 6 · see citing works
Self-citationKharas, N., Yang, P. B., Robles, T., Sanchez, A. N., & Dafny, N. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.12.021 · Cited by 5 · see citing works
Principles in using psychotropic medications in children and adolescents
Vitiello, B. (2012) · Institutional Research Information System University of Turin (University of Turin) · Cited by 4 · see citing works
Prevention of Health Risk Behaviors in ADHD Youth: Is ADHD Treatment Enough?
Schoenfelder, E. N., & Kollins, S. H. (2014) · The ADHD Report · doi:10.1521/adhd.2014.22.4.1 · Cited by 4 · see citing works
Lee, S. M., Cheong, H.-K., Oh, I., & Hong, M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s337819 · Cited by 4 · see citing works
Psychiatric Comorbidities in Adolescent Substance Use Disorders
Zorick, T. S. (2012) · Wiley eBooks · doi:10.1002/9781118340851.ch9 · Cited by 4 · see citing works
A Biological/Genetic Perspective: The Addicted Brain
Kelly, T. H., Kazura, A. N., Lommel, K. M., Babalonis, S. L., & Martin, C. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-09732-9_2 · Cited by 3 · see citing works
Adolescent and Substance Abuse
Milin, R., & Walker, S. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_124 · Cited by 3 · see citing works
Sherman, A. L., Stamates, A. L., & Weyandt, L. L. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251330038 · Cited by 2 · see citing works
- Authors
- Wilens, T. E., Adamson, J., Monuteaux, M. C., Faraone, S. V., Schillinger, M., Westerberg, D., & Biederman, J.
- Affiliations
- Harvard University (US)
- SUNY Upstate Medical University (US)
- Venue
- Archives of Pediatrics & Adolescent Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-10-06
- Volume
- 162
- Issue
- 10
- Pages
- 916
- ISSN
- 1072-4710 (ISSN-L)
- PMC
- PMC2760975
- OpenAlex
- W2134650812
- Cited by
- 136
- References
- 38
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 13 · 2013: 14 · 2012: 15
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Pediatrics and Adolescent Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (K24DA016264, DA R01 DA14419, R01DA014419)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, psychostimulants, adolescent substance use disorders, cigarette smoking, alcohol consumption, drug use, conduct disorder, family history of ADHD
- MeSH terms
- Adolescent, Adolescent Behavior, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Attitude to Health, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Smoking, Time Factors, Comorbidity, Incidence, Confidence Intervals, Proportional Hazards Models, Case-Control Studies, Sex Distribution, Risk Assessment, Substance-Related Disorders, Alcohol-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review